Lack of long-term effect of the method of infant feeding on growth

Human Nutrition. Clinical Nutrition
|January 1, 1985
PubMed

Insights

Children exclusively breast-fed for the first three months were taller and heavier at age 7. However, familial factors, not feeding method, likely explain most differences in later childhood growth.

Area of Science:

  • Pediatrics
  • Human Growth and Development
  • Nutritional Science

Background:

  • Infant feeding practices, such as breastfeeding and formula feeding, are hypothesized to influence long-term child development.
  • Previous studies suggest potential links between infant feeding methods and later childhood physical characteristics.

Purpose of the Study:

  • To investigate the association between exclusive breastfeeding in early infancy and physical development at 7 years of age.
  • To determine if observed differences are attributable to the feeding method itself or confounding familial factors.

Main Methods:

  • Longitudinal study comparing children exclusively breast-fed versus formula-fed in the first 3 months of life.
  • Assessment of anthropometric measures (height, weight, fatfold) and skeletal maturity at 7 years of age.
  • Statistical correction for familial factors including maternal stature and socioeconomic status.

Main Results:

  • Children exclusively breast-fed were significantly taller and slightly heavier at age 7 compared to formula-fed children.
  • These differences were largely explained by confounding familial factors, such as maternal height and socioeconomic status.
  • No significant differences were observed in skeletal maturity or body fatness (triceps plus subscapular fatfold) at age 7.

Conclusions:

  • Apparent associations between infant feeding method and 7-year-old outcomes may be confounded by family characteristics.
  • The method of infant feeding itself may have a limited direct impact on later childhood physical development after accounting for familial factors.
  • Careful interpretation is needed, considering that family background influences feeding choices and child outcomes.

Related Concept Videos

Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience, such as differences...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding01:15

Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding

Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube through...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...